Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nukkleus (NUKK) EBITDA Margin (2022 - 2025)

Historic EBITDA Margin for Nukkleus (NUKK) over the last 4 years, with Q2 2025 value amounting to 1398.4%.

  • Nukkleus' EBITDA Margin fell 4727600.0% to 1398.4% in Q2 2025 from the same period last year, while for Jun 2025 it was 80053.74%, marking a year-over-year decrease of 798001300.0%. This contributed to the annual value of 147.04% for FY2024, which is 650900.0% down from last year.
  • Per Nukkleus' latest filing, its EBITDA Margin stood at 1398.4% for Q2 2025, which was down 4727600.0% from 62523.92% recorded in Q1 2025.
  • Nukkleus' EBITDA Margin's 5-year high stood at 1830.05% during Q3 2024, with a 5-year trough of 62523.92% in Q1 2025.
  • For the 4-year period, Nukkleus' EBITDA Margin averaged around 6445.49%, with its median value being 226.18% (2023).
  • Per our database at Business Quant, Nukkleus' EBITDA Margin surged by 21109000bps in 2024 and then plummeted by -615988900bps in 2025.
  • Quarter analysis of 4 years shows Nukkleus' EBITDA Margin stood at 21.61% in 2022, then crashed by -694bps to 171.51% in 2023, then surged by 1167bps to 1830.05% in 2024, then tumbled by -176bps to 1398.4% in 2025.
  • Its EBITDA Margin stands at 1398.4% for Q2 2025, versus 62523.92% for Q1 2025 and 1830.05% for Q3 2024.